My NCBI | Sign In
RSS Settings
  • Search: Standeven KF[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 12

    1.

    Role of proteomic technologies in understanding risk of arterial thrombosis.

    Polkinghorne VR, Standeven KF, Schroeder V, Carter AM.

    Expert Rev Proteomics. 2009 Oct;6(5):539-50.PMID: 19811075 [PubMed - in process]Related articles

    2.

    Heritability of clot formation.

    Standeven KF, de Willige SU, Carter AM, Grant PJ.

    Semin Thromb Hemost. 2009 Jul;35(5):458-67. Epub 2009 Sep 8.PMID: 19739036 [PubMed - in process]Related articles

    3.

    The pleiotropic role of the fibrinogen gamma' chain in hemostasis.

    de Willige SU, Standeven KF, Philippou H, Ariëns RA.

    Blood. 2009 Nov 5;114(19):3994-4001. Epub 2009 Aug 17.PMID: 19687509 [PubMed - in process]Related articles

    4.

    Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system.

    Ajjan RA, Standeven KF, Khanbhai M, Phoenix F, Gersh KC, Weisel JW, Kearney MT, Ariëns RA, Grant PJ.

    Arterioscler Thromb Vasc Biol. 2009 May;29(5):712-7. Epub 2009 Mar 12.PMID: 19286636 [PubMed - indexed for MEDLINE]Related articles

    5.

    Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity.

    Ajjan R, Lim BC, Standeven KF, Harrand R, Dolling S, Phoenix F, Greaves R, Abou-Saleh RH, Connell S, Smith DA, Weisel JW, Grant PJ, Ariëns RA.

    Blood. 2008 Jan 15;111(2):643-50. Epub 2007 Oct 9.PMID: 17925485 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Fibrin clot structure in patients with end-stage renal disease.

    Sjøland JA, Sidelmann JJ, Brabrand M, Pedersen RS, Pedersen JH, Esbensen K, Standeven KF, Ariëns RA, Gram J.

    Thromb Haemost. 2007 Aug;98(2):339-45.PMID: 17721616 [PubMed - indexed for MEDLINE]Related articles

    7.

    Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness.

    Standeven KF, Carter AM, Grant PJ, Weisel JW, Chernysh I, Masova L, Lord ST, Ariëns RA.

    Blood. 2007 Aug 1;110(3):902-7. Epub 2007 Apr 13.PMID: 17435113 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The molecular physiology and pathology of fibrin structure/function.

    Standeven KF, Ariëns RA, Grant PJ.

    Blood Rev. 2005 Sep;19(5):275-88. Review.PMID: 15963835 [PubMed - indexed for MEDLINE]Related articles

    9.

    Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function.

    Standeven KF, Grant PJ, Carter AM, Scheiner T, Weisel JW, Ariëns RA.

    Circulation. 2003 May 13;107(18):2326-30. Epub 2003 Apr 21.PMID: 12707238 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure.

    Cooper AV, Standeven KF, Ariëns RA.

    Blood. 2003 Jul 15;102(2):535-40. Epub 2003 Mar 27.PMID: 12663453 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Factor XIII A-subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle-aged men.

    Kohler HP, Ariëns RA, Catto AJ, Carter AM, Miller GJ, Cooper JA, Mansfield MW, Standeven KF, Grant PJ.

    Br J Haematol. 2002 Sep;118(3):825-32.PMID: 12181053 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation.

    Standeven KF, Ariëns RA, Whitaker P, Ashcroft AE, Weisel JW, Grant PJ.

    Diabetes. 2002 Jan;51(1):189-97.PMID: 11756340 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity